GM CSF (CSF2) Rat Monoclonal Antibody [Clone ID: SPM469]
Product Images
Specifications
Product Data | |
Clone Name | SPM469 |
Applications | FC, IF, IHC, IP, NEUT, WB |
Recommended Dilution | ELISA: Use BSA free antibody for coating. Neutralization Studies: Use BSA and Azide free antibody. Flow Cytometry: 0.5-1 µg/106 cells. Immunofluorescence: 0.5-1 µg/ml. Western Blot: 0.5-1 µg/ml. Immunoprecipitation: 0.5-1 μg/500 µg protein lysate. Immunohistochemistry on Frozen Sections: 0.5-1 µg/ml for 30 minutes at RT. Positive Control: Lymph node and tonsil. |
Reactivities | Human, Monkey |
Host | Rat |
Isotype | IgG2a |
Clonality | Monoclonal |
Immunogen | Recombinant human GM-CSF protein. |
Specificity | This Monoclonal antibody recognizes GM-CSF (Granulocyte/Macrophage - Colony Stimulating Factor). Cellular Localization: Secreted (extracellular). |
Formulation | 10mM PBS State: Purified State: Liquid purified IgG fraction from Bioreactor Concentrate Stabilizer: 0.05% BSA Preservative: 0.05% Sodium Azide |
Concentration | lot specific |
Purification | Protein A/G Chromatography |
Storage | Store undiluted at 2-8°C. DO NOT FREEZE! |
Stability | Shelf life: one year from despatch. |
Predicted Protein Size | 22 kDa |
Database Link | |
Background | Granulocyte/macrophage - Colony-stimulating factor (GM-CSF) is a hematopoietic factor that is produced by activated T-cells, B-cells, mast cells, macrophages, fibroblasts, and endothelial cells. In addition to supporting colony formation of granulocyte/macrophage progenitors, GM-CSF is a growth factor for erythroid, megakaryocyte, and eosinophil progenitors. |
Synonyms | CSF2, GMCSF, Sargramostim, Molgramostin |
Reference Data |
Documents
Product Manuals |
FAQs |
{0} Product Review(s)
0 Product Review(s)
Submit review
Be the first one to submit a review
Product Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.